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The life span of anergic self-reactive  B cells was determined by 5-bromo-2'-deoxyuridine (BrdU) 
loading of tolerant double-transgenic (Dbl-Tg) mice produced by mating hen egg lysozyme (HEL)- 
transgenic  mice with the corresponding immunoglobulin-transgenic  (Ig-Tg) mice,  the B cells 
of which express anti-HEL IgM and IgD. B cells from Dbl-Tg mice, despite being exposed to 
soluble antigen throughout  their development,  are not deleted, but persist in an anergic state. 
As  a prelude  to  studying  the  life  span  of these  anergic  B  cells,  BrdU  was  administered  to 
nontransgenic mice; B cells from the bone marrow, spleen, and lymph nodes displayed distinct 
kinetic profiles based on reciprocal expression of the B220 isoform of CD45 and heat-stable antigen 
(HSA).  Thus,  immature  B2201~  hi B  cells  incorporated  BrdU rapidly  suggesting  recent 
generation  from  dividing  precursors,  whereas  uptake  by  B  cells  expressing  the  mature 
B220hi/HSA  1~ phenotype was significantly slower, consistent with a longer life span.  Such gating 
allowed analysis to be directed at the stable mature B cell population in transgenic mice. Comparison 
of BrdU uptake in Ig- and Dbl-Tg mice indicated that B cells from Dbl-Tg mice were renewed 
at a much higher rate (50% renewal times of 0.64 vs. 3.4 wk for total B cells, and 1.2 vs. 5.0 
wk  for  mature  B200hi/HSA  1~ cells  from  Dbl-  and  Ig-transgenic  mice,  respectively).  This 
difference was even more marked when analysis in Dbl-Tg mice was restricted to HEL-binding 
cells,  which had a 50%  renewal time of 3-4 d compared with 4-5 wk for non-HEL-binding 
B cells.  While the proportion of B cells in cell cycle, and the rate of entry of newly generated 
B cells into the spleen of Ig- and Dbl-Tg mice, were similar,  B cell numbers were reduced in 
Dbl-Tg mice. It was therefore concluded that anergic B cells have a markedly decreased life span 
in the periphery.  According to studies in radiation chimeras produced by reconstituting  HEL- 
transgenic recipients expressing different serum levels of antigen with Ig-Tg bone marrow, the 
reduced life  span  of anergic  B  cells  was  associated with  the  anergic  state per  se,  the  serum 
concentration of HEL being important only in attaining the critical threshold necessary for tolerance 
induction.  B cells rendered tolerant by exposure to soluble self-antigen therefore survive for a 
relatively short period in an anergic state once they have reached peripheral lymphoid tissue and 
fail to enter the long-lived compartment.  These findings have implications for the maintenance 
of self-tolerance and induction of autoimmunity in both B cell and T cell repertoires and suggest 
that  the distinction  between B cell anergy and deletion is more relative than  absolute. 
S 
tudies  in  double-transgenic  (Dbl-Tg) 1 mice  containing 
endogenously expressed antigen and monoclonal popu- 
lations  of T  cells  and  B  cells  of the  same specificity have 
confirmed that the predominant mechanisms responsible for 
self-tolerance are clonal deletion and anergy (1-5). In our hen 
egg  lysozyme (HEL)/anti-HEL  transgenic  model  of self- 
tolerance,  the fate of autoreactive B cells was shown to be 
determined  predominantly by the structure  of the neoself- 
1 Abbreviations used in this  paper: BrdU, 5-bromo-2'-deoxyuridine;  Dbl-Tg, 
double-transgenic; HEL, hen egg lysozyme; HSA, heat-stable antigen. 
antigen  (6).  When mice transgenic  for anti-HEL IgM and 
IgD (Ig-Tg) were mated with HEL transgenic mice expressing 
the antigen in membrane bound form (mHEL-Tg), the Dbl- 
Tg offspring were tolerant,  and very few B cells expressing 
transgene-encoded Ig were detected in peripheral lymphoid 
tissue (7).  This proved to be the result of a block in B cell 
differentiation at an immature stage within the bone marrow; 
loading studies using 5-bromo-2'-deoxyuridine (BrdU) showed 
that these cells had an average life span of ~15 h (8). By con- 
trast, B cells exposed to HEL in soluble form (sHEL) were 
not  deleted  from  peripheral  lymphoid  tissue;  rather,  a 
significant proportion of them appeared to migrate normally 
from bone marrow to spleen where they colonized the B cell 
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tion of IgM but  not  IgD  antigen  receptors (9). 
The apparent persistence of potentially self-reactive B cells 
in spleen and lymph node poses questions  about  their role 
both in maintenance of self-tolerance and induction of auto- 
immunity. However meaningful answers depend on knowing 
the renewal rate and longevity of these B cells once they have 
been rendered anergic. 
The  aim  of this  paper was  to  compare  the life span  of 
transgene-encoded  B  cells from  tolerant  sHEL-Dbl-Tg  vs. 
Ig-Tg mice by continuous loading with BrdU.  Mature pe- 
ripheral B cells defined by the B220hiHSA  l~ phenotype in the 
spleen and bone marrow of nontolerant Ig-Tg controls had 
a 50% renewal rate of 5-6 wk whereas this figure was greatly 
reduced for anergic B cells from Dbl-Tg mice, being as low 
as 3-4 d when analysis was confined to HEL-binding cells. 
These findings challenge the dogma that deletion and anergy 
are completely distinct  processes and point to a  single fate 
for B cells rendered tolerant by interaction with self-antigen 
in  the  absence of costimulatory  signals. 
Materials and Methods 
Mice.  Conventional inbred C57BL/6 (B6), SJL/J, and (B6 x 
SJL/J)F~ strains  of mice and transgenic mouse lines were housed 
under standard conditions in the University of Sydney animal fa- 
cility.  Hemizygous Ig and HEL transgenic lines were maintained 
on a B6 or (B6  x  SJL/J)F1 background by backcrosses with non- 
transgenic mice.  The Ig-Tg mice belonged to the MD4 line,  the 
B cells from which expressed high a~nity IgM and IgD receptors 
for HEL (10). In the HEL-Tg mice, HEL was expressed in soluble 
form under control of the mouse metallothionein-1 promoter (lines 
ML4,  ML5) or the albumin  promoter (line  AL3) (11). Soluble 
HEL-Dbl-Tg mice were created by mating ML5 HELTg with MD4 
Ig-Tg mice. 
Cell Suspensions.  Mice were sacrificed by cervical dislocation, 
the spleen,  or inguinal lymph nodes were dissected  out, gently 
pressed through a sieve using a syringe plunger, and suspended in 
PBS supplemented with protein (0.1% BSA or 2% FCS;  Com- 
monwealth Serum Laboratories, Victoria, Australia)  and 0.1% so- 
dium azide.  Bone marrow suspensions  were prepared by flushing 
femurs in both directions with the same medium. 
Bone Marrow Chimeras.  Non-Tg or sHEL-Tg mice (from ML4, 
ML5, or AL3 lines),  aged at least 3 too, were lethally irradiated 
(950 rad) and reconstituted by intravenous injection of 2.5  x  106 
bone marrow cells from MD4 Ig-Tg donors. The resultant chimeras 
were used at least  9 wk  after reconstitution. 
Monoclonal Antibodies.  The following mAbs were used (speci- 
ficities in parentheses): HyHEL5 (HEL [12]); RA3-6B2 (B220 [13]); 
M1/69 (heat-stable antigen [HSA] [14]); and BU-44 (BrdU [15]). 
Details on ftuorochrome conjugates are given in the subsequent 
sections.  Aggregates  from  FITC-conjugated  and  biotinylated 
mAbs were removed before use by centrifugation in an Airfuge  TM 
(Beckman Instruments,  Palo Alto, CA) at 28 psi  for 15 rain. 
Administration of  BrdU.  BrdU (Sigma Chemical Co., St. Louis, 
MO) was administered to mice in the drinking water at a concen- 
tration of 0.25 mg/ml for 1-6 wk. This dose was selected on the 
basis of preliminary experiments that indicated that it resulted in 
suffacient DNA incorporation to permit ready discrimination be- 
tween BrdU-positive and -negative cells in the absence of signifcant 
bone marrow toxicity. Water bottles containing BrdU were shielded 
from the light and changed twice weekly. 
BrdU Assay.  The method used to detect BrdU in B cell DNA 
was as reported previously (8). Briefly, suspensions of bone marrow 
and spleen cells were labeled with biotinylated anti-HSA antibody. 
After fixing in 0.5%  paraformaldehyde in PBS (20 rain), DNA 
was denatured using 3-N HCI supplemented with 0.5% Tween 
20 to permeabolize the cell membrane (20 rain). The acid was then 
neutralized with 0.1 M disodium tetraborate (3 min) and the cells 
were stained with FITG-conjugated anti-BrdU and PE-conjugated 
anti-B220 antibodies. The biotinylated antibody was developed with 
streptavidin conjugated to Tricolor  TM  (Caltag,  South San Fran- 
cisco,  CA) or Quantum  Red (Sigma  Chemical Co.). Although 
Tricolor  TM  and Quantum  Red bind  to HEL nonspecifically  on 
fresh cells (our unpublished observations), this did not appear to 
occur after the fixation and denaturation procedure used here. The 
HEL-binding assay was performed in an identical fashion  to the 
above except that the anti-HSA staining step was replaced by a sand- 
wich stain involving incubation with HEL followed by biotinylated 
HyHEL5. Listmode data on  1.0-1.5  x  104 lymphocyte events 
were collected. Analysis gates for BrdU incorporation were set be- 
tween two clearly separate populations, the negative population 
corresponding to that obtained in control mice not fed BrdU. 
FACS |  Analysis.  Cell suspensions  stained  as described  previ- 
ously were subjected  to three-color analysis on a FACScan  |  flow 
cytometer (Becton Dickinson & Co., Mountain View, CA) which 
collected data on forward and orthogonal light scatter and fluores- 
cence intensity. Compensation for spectral  overlap was based on 
the fluorescent signal from singly labeled cells. Listmode data were 
collected and analyzed using LYSIS 2.0 software on a Hewlett- 
Packard computer. 
Cell Cycle Analysis.  106 spleen or bone marrow cells were la- 
beled either with anti-B220 directly conjugated to FITC, or HEL 
(200 ng/ml, Sigma Chemical Co.) followed by FITC-conjugated 
HyHEL5. Cells were fixed by the dropwise addition of ice-cold 
70% ethanol and kept at 4~  for up to 1 wk. They were then 
resuspended in PBS with 1% glucose, 50/lg/ml propidium iodide 
(Sigma Chemical Co.), and 80 ng/ml RNase, DNase-free (Boeh- 
ringer-Mannheim, Mannheim, Germany). Stained cells were ana- 
lyzed by two-color flow cytometry with propidium iodide fluores- 
cence being detected by linear amplification of the signal from the 
second fluorescent channel. Listmode data on 3-5  x  104 events 
were collected;  doublets were removed from analysis using  the 
doublet-discrimination module and singlet gating based  on the 
width of the signal  from the second fluorescent channel. DNA 
content was determined by the height of this signal after gating 
on cells exhibiting a lymphocyte scatter profile that also expressed 
B220 or bound HEL. 
Analysis of BrdU Uptake Patterns.  The pattern of appearance 
of BrdU-positive cells within a defined population during loading 
studies is dependent on its kinetic makeup. A population that is 
slowly but continually renewed from precursors will show a smooth 
gradual uptake pattern the slope of which is dependent on the av- 
erage life span of that population (single-order kinetics). Alterna- 
tively, a cell population may contain a combination of short- and 
long-lived cells; in this case a rapid increase in labeling occurs until 
almost 100% of the short-lived population has incorporated BrdU, 
followed by a more gradual increase, representing the slower renewal 
of the longer-lived population. Consequently the BrdU labeling 
data are presented in terms of the time taken to label 50% of the 
population, referred to subsequently as the 50% renewal time. To 
calculate this, BrdU uptake data were plotted, a line of best fit was 
drawn, and the time to 50% labeling was estimated. While such 
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kinetics, in many cases the appearance of BrdU-labeled cells in a 
first-order kinetic population  was found to follow a pattern  that 
could best be described by the exponential decay of the unlabeled 
population.  Based on this assumption,  the 50% renewal time is 
equivalent to the population  half-life. 
Results 
Expression of  B220 and lISA Defines Distinct Kinetic Popula- 
tions in Central and Peripheral Lymphoid Tissue.  The various 
stages in B cell maturation can be defined by reciprocal changes 
in expression of the two surface markers, B220 and HSA (16, 
17). Thus,  pre-B and immature B cells express the B2201~ 
HSA  hi phenotype whereas mature B cells are B220WHSA  1~ 
Initially,  BrdU loading was carried out in non-Tg mice to 
determine whether the two B cell populations defined by B220 
and HSA expression had distinct kinetic profiles.  Non-Tg B6 
or (B6  x  SJL/J)F~ mice were given BrdU for 7 d and up- 
take was assessed in B cells obtained from the bone marrow, 
spleen, and lymph nodes by three-color FACS  |  analysis.  As 
shown in Fig. 1 A, good discrimination between immature 
B220WHSA  hi  and  mature  B220hi/HSA 1~ B  cells  was  ob- 
tained.  In the bone marrow, BrdU-positive B cells accumu- 
lated rapidly, 61% being labeled over the 7-d loading period 
(Fig.  2). This figure rose to almost 100% when uptake was 
assessed in the immature B2201~  hi subset, which made 
up ~29%  of bone marrow lymphocytes (Fig.  1 and Table 
1).  On  the  other  hand,  B  cells  expressing  the  mature 
B220hi/HSA  1~ phenotype  took  up  BrdU  more  slowly,  so 
that only 11% were labeled over the same time period (Fig. 
2).  These  cells  represented  IgD-positive  B  cells  that  had 
returned from the periphery to the bone marrow (18) where 
they comprised about a quarter of the lymphocytes (Table 1). 
Analysis of the BrdU uptake pattern of B cells in the spleen 
and lymph nodes revealed  the presence of the same kineti- 
cally distinct populations (Fig. 2) with rapid turnover of the 
B2201~  hi cells and  slow renewal  of the B220hi/HSA  1~ 
cells. Comparison with F1 mice was undertaken in view of 
preliminary work suggesting that they were more resistant 
to the toxic effects of prolonged BrdU administration  than 
B6 mice (data not shown).  In practice,  uptake of BrdU at 
7 d was similar in the two strains (Fig.  2) and no evidence 
of increased toxicity in B6 mice was observed at  the rela- 
tively low dose of 0.25 mg/ml used. These observations re- 
mained  valid during prolonged BrdU loading  for up  to 6 
wk (data not shown). Consequently, transgenic mice on the 
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Figure  1.  Analysis gating for BrdU uptake. (.4) Bone 
marrow and spleen from non-Tg, Ig-Tg, and ML5 Dbl-Tg 
mice on a B6 background.  Two distinct B220-positive 
populations were discernable in the bone marrow, namely 
B2201o/HSA  hi cells and B220hi/HSA  1~ cells. Although the 
spleen shows a more continuous range of B220 and HSA 
expression,  analysis gates  defined  by expression  in  the 
marrow were applied. The 10% probability contour plots 
were  gated on  small  lymphocytes  by forward  and  or- 
thogonal light scatter. Percentages shown represent values 
from individual  mice; the means  (+  SD) of values for 
B2201o/HSA hi and B220hi/HSA l~ respectively, from the 
cohort of mice used in the experiment  detailed in the text 
were as follows: Spleen, Non-Tg, 14 _+ 2.2 and 47 + 4.9%; 
Ig-Tg, 12  _+ 3.4 and 36  -+ 6.8%; Dbl-Tg, 13  _+  2.8 and 
15  -+ 4.9%; Bone marrow values shown in Table 1. (B) 
BrdU fluorescence histograms  from the bone marrow of 
a non-Tg B6 mouse after 1-wk's loading with BrdU. Up- 
take was  determined  by gating on B2201~  hi cells 
(top) or B220hi/HSA 1~ cells (bottom) being 96 and 13%, 
respectively, as shown in Fig. 2. (C) Spleen cells from a 
Dbl-Tg mouse showing the gates applied to determine the 
BrdU uptake of HEL-binding and non-HEL-binding B cells. 
10%  probability  contour plot. 
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Figure 2.  BrdU uptake in bone marrow, spleen, and lymph node of 
adult (age, >3 mo) B6 (open circles) or (B6 x SJL/J)F1 mice (closed circles) 
given BrdU for 7 d. Gates shown in Fig. 1 A were applied to determine 
BrdU uptake in B220-positive cells (unshaded bars), immature B2201~ 
HSA  hi cells (hatched bars), or mature B220hi/HSA  I~ (stippled bars). The rel- 
ative proportions of the two populations varied in the three tissues exam- 
ined; B2201~  hi cells represented  56% of marrow B220-positive  cells, 
25 % of splenic B220-positive  cells, and 12% of lymph node B220-positive 
cells. 
two backgrounds were used interchangeably in subsequent 
experiments  (see below). 
The  findings  described  here  established  that  immature 
B2201~  hi and mature B220hi/HSA 1~ B cells from both 
central and peripheral lymphoid tissue of non-Tg mice dis- 
play distinct kinetic profiles. Three-color FACS  |  analysis using 
B220 and HSA was therefore repeated on B cells from MD4 
Ig-Tg and ML5 Dbl-Tg mice on a B6 background. As shown 
in Fig. 1 A, the FACS  |  profiles for Ig-Tg and Dbl-Tg B cells 
were similar  to those from non-Tg mice.  Moreover, in the 
tolerant Dbl-Tg mice, by substituting HEL/HyHELSBi for 
HSA during the staining procedure, it was possible to subdi- 
vide B cells into two further populations on the basis of their 
capacity to bind  HEL (Fig.  1 C  and  see below). 
Higher  Rate  of BrdU  Uptake  in  B  Cells from  Dbl-Tg 
Mice.  Based  on  the  labeling  technique  described  in  the 
previous section, the life span of anergic B cells was deter- 
mined by comparing their turnover in ML5 Dbl-Tg mice with 
that in Ig-Tg mice on a B6 background during continuous 
loading with BrdU  for 6 wk.  At  all timepoints  analyzed, 
the BrdU uptake by B cells from Dbl-Tg mice was significantly 
higher than in Ig-Tg mice, resulting in a fivefold reduction 
in their 50%  renewal time (Fig.  3 A  and Table  1).  When 
the rapidly labeling B2201~  hi cells were excluded to re- 
strict  analysis  to  mature  B220hi/HSA l~ cells,  the  higher 
BrdU-uptake by Dbl-Tg B cells was still clearly evident, the 
50%  renewal  time being decreased fourfold (Fig.  3 B  and 
Table 1). The rate of BrdU uptake by Ig-Tg B cells was similar 
to that  of non-Tg mice (Table 1) and was  consistent  with 
earlier life span  estimates  of 5-6  wk  (19,  20). 
BrdU uptake by B220-positive cells from both Ig-Tg and 
Dbl-Tg mice displayed a second-order kinetic pattern with 
an initial rapid labeling phase over the first 1-2 wk followed 
by a slower increase thereafter. In Ig-Tg mice, this effect dis- 
appeared when the newly generated B220a~  hi cells were 
excluded from the analysis (Fig. 3 B). By contrast,  anergic 
Dbl-Tg B cells displayed a second-order pattern whether or 
not  the B2201~  hi cells had  been  excluded (Fig.  3  B). 
This was  subsequently  shown  to be due to a difference in 
kinetics of HEL-binding vs.  non-HEL-binding  B cells (see 
below). 
A similar trend was observed when the experiments were 
repeated  in  Dbl-Tg  and  Ig-Tg  mice  bred  on  a  (B6  x 
SJL/J)F1 background.  Thus,  there was a markedly reduced 
50% renewal time of B cells from the Dbl-Tg mice, the de- 
Table  1.  Comparison of B  Cell Composition and 50%  Renewal  Times in Non-Tg,  Ig-Tg,  and ML5 Dbl-Tg Mice 
Spleen  B cells  Bone marrow B cells  50%  Renewal time 
Mouse strain  Total  B220hi/HSA  1~  B2201~  hi  B220hi/HSAl~  Total B cell  B220hi/HSA 1~ 
X 10 -6  ~0  oflyn~lphocytes  wk 
B6 mice* 
Non-Tg  84  _+  21s  65  _+  16  29  _+  7.3  24  _+  9.5  3.9  5.1 
Ig-Tg  28  _+  14  21  _+  9.8  12  _+ 3.2  16  _+  8.2  3.4  5.0 
Dbl-Tg  15  _+  6.4  8  _+ 3.1  18  _+ 3.1  4  _+ 2.6  0.64  1.2 
Reduction in Dbl-Tg  46%  62%  0%  75%  81%  76% 
(B6  x  SJL)F1 micO 
Ig-Tg  55  +  10  46  _+  7.8  15  +  9.2  17  _+ 3.0  5.4  7.0 
Dbl-Tg  6.7  _+ 3.4  3.1  +  1.9  14  +  4.8  1.0  _+ 0.4  0.52  1.1 
Reduction in Dbl-Tg  88%  93%  7%  94%  90%  84% 
* Mice were 18-33 wk of age. Data were derived from 21 non-Tg,  13 Ig-Tg,  and 10 Dbl-Tg mice. 
* Mice were 23-40 wk of age. Data were derived from eight Ig-Tg and nine Dbl-Tg mice. 
S Values are mean _+ SD. 
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Figure  3.  (A-D)BrdUuptakein 
splenic B cells from Ig-Tg and Dbl-Tg 
B6  mice  during  a  6-wk  loading 
period. (A) Gating on all B220-posi- 
tive cells.  (B)  Gating  on B220hi/ 
HSA  1~ cells. (C) Percentage uptake 
curves from A  corrected for abso- 
lute numbers of B cells. (D) Turn- 
over of splenic B cells in Dbl-Tg mice 
based on their ability to bind HEL. 
The mean age of mice at commence- 
ment of BrdU loading was 24 wk 
(range, 18-30 wk). (E and F) BrdU 
uptake in splenic B cells from radi- 
ation chimeras produced by recon- 
stituting  non-Tg  (open circles)  or 
sHEL-Tg (closed circles) B6 mice with 
MD4  Ig-Tg bone  marrow.  (E) 
sHEL-Tg line AL3, which expresses 
high serum levels of HEL (20-110 
ng/ml);  (F)  sHEL-Tg line  ML4, 
which expresses  low HEL levels (<1 
ng/ml).  Where necessary, plotted 
points  have been staggered  when 
overlapping with others. Values are 
from individual mice. Curves  rep- 
resent line of best  fit. 
crease  affecting  both  total  B  cells  and B220hi/HSA 10 cells 
(Table  1). 
B  Cell Numbers and Celt Cycle Analysis in Ig-Tg and Dbt-Tg 
Mice.  The  higher rate  of BrdU uptake by anergic B  ceils 
from Dbl-Tg mice is consistent with a reduction in life span. 
In theory,  however, this could have been due to an increase 
in their rate of cell division as a result of persistent exposure 
to antigen. Indeed, although the Dbl-Tg mice were tolerant 
in vivo, the anergic B ceils had been shown to proliferate better 
than their Ig-Tg counterparts after removal from the tolerant 
environment and stimulation in vitro with LPS (21) or a T 
cell membrane preparation containing the CO40 ligand (Eris, 
J., A. Basten, M. Kehry, and P. Hodgkin,  manuscript sub- 
mitted for publication) even in the presence of HEL. To ex- 
clude this alternate  explanation for the increase  in BrdU in- 
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corporation by anergic B  cells,  the absolute numbers of B 
cells, the rate of splenic input of B cells from the bone marrow, 
and the proportion of B cells entering the cell cycle were de- 
termined  in Dbl-Tg  vs.  Ig-Tg  mice. 
B cell populations from the bone marrow and spleen of 
the same Ig and Dbl-Tg  mice used in the previous section 
were analyzed for cell numbers and maturity.  The propor- 
tion of small bone marrow lymphocytes (by foward and side 
scatter) that were of immature B2201~  hi phenotype was 
similar in Ig-Tg and Dbl-Tg  mice on both B6  and (B6  x 
SJL/J)F1 backgrounds (Table 1). However, the proportion of 
mature B220hi/HSA t~ cells in the marrow was reduced 4-fold 
in Dbl-Tg compared with Ig-Tg mice on a B6 background, 
and more than 10-fold in those bred on the (B6  x  SJL/J)F1 
background. These findings were mirrored in the spleen, where a marked decrease in total B cells and B220hi/HSA  l~ B cells 
in Dbl-Tg compared with Ig-Tg mice was again observed, 
closely matching the reduction in 50% renewal time (Table 
1). Although such a marked decrease in B cell numbers had 
not been reported previously in Dbl-Tg mice,  the animals 
from earlier experiments were much younger (,o6 wk of age) 
than those used in the present study (18-33 wk). BrdU loading 
experiments have been developed and are currently underway 
to determine precisely what changes in B cell number and 
life span do occur as the  transgenic  mice mature. 
The rate of input of newly labeled B cells into the spleen 
was estimated by applying the BrdU uptake curves to the 
total B cell numbers  in Ig-Tg and Dbl-Tg mice.  The rates 
of input  of total B cells and of mature B220hi/HSA  1~ cells 
(given by the slopes of the respective curves at  the origin) 
were similar in the two groups  (Fig.  3 C),  making it un- 
likely that  an alteration  in generation  or export of B cells 
from the marrow was the explanation  for the difference in 
B cell numbers. Moreover, the finding speaks against the pos- 
sibility of enhanced proliferation by B cells in the peripheral 
lymphoid tissue of Dbl-Tg mice. 
Finally,  the background rate of proliferation of splenic B 
cells from Ig compared with Dbl-Tg mice was measured by 
analyzing their DNA content on the basis of B220 expres- 
sion or their ability to bind HEL. Normal age-matched B6 
or (B6  x  SJL/J)F1 mice served as controls. The proportion 
of cycling B cells was lower in both the Ig-Tg and Dbl-Tg 
mice than in controls (Fig. 4), perhaps reflecting a restriction 
in antigen-receptor repertoire. On the other hand, no signi- 
ficant differences in the percentages of cycling cells were ob- 
served between Ig-Tg and Dbl-Tg mice, whether they were 
analyzed by B220 expression or by HEL-binding.  Taken to- 
gether, these findings support the conclusion that anergic B 
cells in Dbl-Tg mice do indeed have a markedly reduced life 
span in vivo. 
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Figure 4.  Cell  cycle  analysis of B220-positive, or HEL-binding, splenic 
cells from Non-Tg (B6 or (B6 x SJL/J)F1 strain), Ig-Tg or ML5 Dbl-Tg 
(B6 strain) mice aged between 7 wk and 9 mo. Percentages of cells out 
of G0/1 phase are shown, with horizontal bars representing the means. 
Positive controls consisting of bone marrow B cells showed rates of be- 
tween 7 and 15% (data not shown). 
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Reduced Life Span of Anergic B Cells Is Due to Rapid Turn- 
over of  HEL-Binding Cells.  Tolerance induction in B cells from 
Dbl-Tg mice depends on a threshold occupancy of Ig-receptors 
by HEL of between 5 and 45% (22). The reduction in life 
span of anergic B cells was presumably a result of antigen 
binding to their surface receptors. To confirm this, use was 
made of the fact that a small proportion of B cells from Dbl-Tg 
mice fails to bind HEL despite continued expression of the 
transgenic IgH a marker, due to endogenous light chain rear- 
rangement  (Crosbie, J.,  unpublished  observations).  Hence 
it was possible to separate the B220-positive cells of Dbl-Tg 
mice into HEL-binding and non-HEL-binding populations 
(Fig.  1 C) and to determine the life span of each population 
separately by loading  with  BrdU over the  standard  6-wk 
period. 
Approximately 75% of splenic B cells bound HEL while 
the remainder did not.  The HEL-binding B cells were very 
short-lived, with a 50% renewal rate of 3.4 d, whereas the 
non-HEL-binding B cells had a 50% turnover almost 10 times 
as great,  namely 4.6 wk (Fig.  3 D), which was similar to 
the rate of renewal of Ig-Tg B cells (Fig.  3 A  and Table 2). 
These results therefore provided a powerful internal control 
for the studies performed in individual Ig- or Dbl-Tg mice 
and reconfirmed the finding of a markedly reduced life span 
for anergic  B cells. 
Life Span of lg-Tg B  Cells Is Reduced  in sHEL-expressing 
Chimeras.  The differential renewal time of B cells from Ig 
vs. Dbl-Tg mice, and of HEL-binding vs. non-HEL-binding 
B cells in Dbl-Tg mice, confirmed that the reduced life span 
of anergic B cells is a consequence of antigen binding to the 
surface receptors. However, antigen expression in the ML5- 
strain mice is under control of the metallothionein promoter, 
which may lead to synthesis of HEL in addition  to small 
amounts of anti-HEL antibody by Dbl-Tg B cells (23). Con- 
sequently the reduction in life span of anergic B cells might 
have been artifactual due to complexing of antigen and anti- 
body within or on the surface of these cells. This possibility 
was obviated by reconstituting irradiated ML5 sHEL-Tg mice 
with bone marrow from MD4 Ig-Tg donors, with non-Tg 
Table  2.  Comparison of B Cell Composition and 50%  Renewal 
Times in Ig-Tg and ML5 Dbl-Tg Mice, Gating on HEL or 
non-HEL-binding B  Cells 
Mouse strain  Spleen B cells  50%  Renewal time 
10 -6  Wk 
Ig-Tg* 
(HEL binding)  28  _+  14  3.4 
Dbl-Tg 
(Non-HEL binding*)  3.4  +  1.2  4.6 
Dbl-Tg 
(HEL binding*)  10.5  _+ 3.4  0.49 
* From Table 1. 
t B6 strain mice at 18-33 wk of age; data were derived from eight mice. recipients serving as controls. Both groups of mice were then 
loaded  with  BrdU  over  6  wk  as  previously  described  in 
Materials  and  Methods. 
A  significant  reduction  in  B  cell  life  span  in  sHEL-Tg 
recipients  compared with  non-Tg  recipients  was observed, 
as  demonstrated  by  a  more  rapid  accumulation  of BrdU- 
positive cells and a decline of similar magnitude in total and 
mature  B220hi/HSA l~ B  cell  numbers  in  the  former  mice 
(Table 3).  Although  the decrease in 50%  renewal time was 
less dramatic than in intact Dbl-Tg mice, the difference be- 
tween  sHEL-Tg recipients  and  controls  was clear  cut  and 
confirmed that  the reduced  life span of anergic B  cells is a 
real  phenomenon. 
Reduction in Life Span of Dbl-Tg B  Cells Correlates with the 
Anergic State.  Clearly B cells rendered anergic by encounter 
with soluble self-antigen have a significantly reduced life span. 
The question  therefore arose as to whether  the decrease in 
life span is a property of the anergic B cells per se or reflects 
the  concentration  of sHEL  and  the  degree  of receptor  oc  o 
cupancy by antigen on the B cell membrane. To distinguish 
between these two possibilities BrdU uptake was measured 
in  chimeras  constructed  by transferring  MD4  Ig-Tg bone 
marrow cells into sHEL-Tg recipients from two other lines 
(AL3  and  ML4)  expressing  different  concentrations  of an- 
tigen  under  control  of  the  albumin  and  metallothionein 
promoters, respectively. The AL3 line was selected since the 
mean  serum level of HEL (20-110  ng/ml)  is up to four to 
five times higher than that of ML5  (15-20 ng/ml),  and the 
B cell compartment is, as expected, tolerant (our unpublished 
observations). By contrast, ML4 mice express very low levels 
of sHEL (<1 ng/ml),  which induces tolerance in the T  cell 
but not the B cell compartment and therefore is not associated 
with  B  cell  anergy in  ML4  Dbl-Tg mice  (11). 
When  the kinetic activity of B  cells from AL3 chimeras 
was compared with  that in non-Tg controls,  a marked de- 
crease in  50%  renewal  time was  again  observed,  but  both 
the degree of the reduction  and the associated fall in B cell 
numbers was almost identical  to the results obtained for B 
cells from" ML5  recipients  (Fig.  3 E  and Table 3).  By con- 
trast,  in  the  ML4  recipients,  no  significant  reduction  in B 
cell numbers occurred (Table 3) and BrdU uptake was almost 
identical to that in non-Tg recipients (Fig. 3 F  and Table 3). 
When taken in the context of the previous findings, the data 
provide  strong  support  for the concept  that  the  reduction 
in life span orb cells from tolerant mice is related to the anergic 
state per se and antigen concentration in serum or on surface 
Ig receptors is only important in attaining the critical threshold 
necessary for induction  of B  cell anergy. 
Table  3.  Comparison of B Cell Composition and 50% Renewal Times in Non-Tg or sHEL-Tg Radiation Chimaeras, Reconstituted 
with MD4 Ig-Tg Bone Marrow 
Transgene combination 
Spleen  B cells  Bone marrow B cells  50%  Renewal time 
Total  B220hi/HSA I~  B2201~  hi  B220hi/HSA l~  Total B  cell  B220hi/HSA  1~ 
x 10 -6  % of lymlohocytes  wk 
ML5  Recipient  chimeras* 
Non-Tg  61  +  22  52  _+  20  13  +  4.4 
sHEL-Tg  19  _+  12  10  +  7.7  14  +_  5.6 
Reduction  in  sHEL-Tg  69%  81%  0% 
AL3  Recipient  chimeras* 
Non-Tg  71  +  17  55  -+  14  19  _+  7.1 
sHEL-Tg  22  +  7.4  14  _+  5.1  21  +  6.6 
Reduction  in  sHEL-Tg  69%  75%  0% 
ML4 Recipient  chimerasS 
Non-Tg  41  _+  8.1  31  +  6.1 
sHEL-Tg  46  _+  18  32  +  13 
Reduction  in  sHEL-Tg  0%  0% 
31  +  9.2  3.8  4.9 
2.5  +  1.6  1.1  2.0 
92%  71%  59% 
24  _+  6.4  2.7  3.8 
4.7  +  2.4  1.1  2.0 
80%  59%  47% 
D  3.9  5.1 
3.4  4.8 
13%  6% 
MLS, AL3, and ML4 are sHEL-Tg lines that express moderate (15-20 ng/ml), high  (20-110 ng/ml), or low serum HEL levels, respectively. 
* ML5 mice were on a (B6  x  SJL/J)F1  background and were used 9 wk after bone marrow reconstitution.  Data were derived from 10 non-Tg 
and 10 ML5 sHEL-Tg recipients. 
* AL3 mice were on a B6 background and were used 9 wk after bone marrow reconstitution.  Data were derived from seven non-Tg and nine AL3 
sHEL-Tg recipients. 
S ML4 mice were on a B6 background and were used 19 wk after bone marrow reconstitution.  Data were derived from eight non-Tg and eight 
ML4 sHEL-Tg recipients. 
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Self-tolerance in the B cell repertoire is mediated predomi- 
nantly by either deletion or anergy (6, 24-26).  Since selec- 
tion  is  thought  to  be  involved  in  both  these  processes, 
measurement  of life span  of tolerant  B cells  with  a DNA 
precursor like BrdU has the potential to shed additional light 
on the cellular mechanisms underlying each of them. To ob- 
tain meaningful results on the life span of self-reactive B cells 
with a single antigenic specificity,  use was made of our well- 
defined double transgenic  model of self-tolerance in which 
monoclonal populations of HEL reactive B cells exposed to 
soluble or membrane-bound  HEL are rendered  anergic  (9, 
22)  or undergo  deletion  (7),  respectively. 
Initially it was important to establish that the BrdU labeling 
technique could distinguish  clearly between immature  and 
mature B cells in the bone marrow and peripheral lymphoid 
tissue since induction  of tolerance to soluble HEL has the 
potential to influence the life span of B cells at any stage during 
maturation.  This goal was achieved by performing three-color 
FACS  |  analysis  on lymphoid cells from nontransgenic mice 
with monoclonal antibodies to the reciprocally expressed B 
cell maturation markers B220 and HSA as well as BrdU (Fig. 
1). In the bone marrow of nontransgenic mice given BrdU 
for 1 wk, almost  100%  of immature B2201~  hi B cells 
were labeled and remained so for as long as BrdU was given 
(Fig.  2 and data not  shown)  (18).  Thus,  the entire cohort 
of B cells exported from the bone marrow to the periphery 
were BrdU positive, which meant that the rate of appearance 
of labeled cells in the spleen or lymph node represented the 
turnover of that population and hence its average life span, 
as reported previously (19).  B cells with the B2201~  hi 
phenotype in the periphery, like those in the bone marrow, 
were  rapidly  labeled  whereas  uptake  of BrdU  by mature 
B220hi/HSA l~ cells occurred more slowly. Hence the short- 
and long-lived B cell populations corresponded closely to the 
immature and mature B cell subsets defined by reciprocal ex- 
pression of B220 and HSA.  In addition,  the same clearcut 
distinction  in life  span between the  two populations  of B 
cells was observed in Ig and Dbl-Tg mice when cells from 
their lymphoid tissues were subjected to similar FACS  |  anal- 
ysis (Figs.  1 A  and  3,  and data not  shown). 
By comparison with mature Ig-Tg B cells, anergic  B220hi/ 
HSA  l~ B-cells from tolerant ML5 Dbl-Tg mice incorporated 
BrdU significantly more rapidly (Fig. 3). The decreased life 
span was not due to an intracellular interaction between an- 
tibody and antigen within the cells, since a comparable differ- 
ence in BrdU uptake occurred in radiation chimeras produced 
by reconstituting ML5 sHEL-Tg mice with MD4 Ig-Tg bone 
marrow (Table 3 and Fig. 3, E and F). Moreover the propor- 
tion of mature B cells in cycle (Fig.  4) and the rate of entry 
of newly generated B cells  into the spleen of Dbl-Tg mice 
(Fig.  3 C) were comparable to those in the Ig-Tg controls 
despite being exposed to  sHEL throughout  their  develop- 
ment. These data, when taken in conjunction with the reduc- 
tion in total and B220hi/HSA l~ B cell numbers (Tables 1 and 
3), indicate that anergic B cells do indeed have a reduced life 
span. 
The differential rates of B cell turnover were even more 
dramatic when analysis was restricted to HEL-binding cells 
alone; in this case HEL-binding anergic B cells died within 
3-4 d of reaching the spleen, while non-HEL-binding B cells 
had a renewal rate of 4-5 wk similar to B cells from non- 
tolerant Ig-Tg mice. Consequently it was predictable that the 
shortened life span of mature B cells from Dbl-Tg mice proved 
to be associated with  their anergic  state (Fig.  3, E  and F, 
and Table  3).  In other words, receptor occupancy by HEL 
above the critical threshold required to induce tolerance ap- 
peared to be responsible for the observed reduction in life 
span presumably due to downstream effects on intracellular 
signaling pathways. Consistent with this conclusion was the 
normal life span of B cells from ML4 chimeras that were not 
tolerant but rather displayed clonal "ignorance" of HEL (24). 
In previous studies Ig-Tg B cells exposed to HEL in mul- 
tivalent membrane-bound  rather  than  soluble form during 
early development in the bone marrow were shown to un- 
dergo maturation  arrest  followed by rapid deletion within 
'-15 h, which prevented their release into the periphery (8). 
Although  exposure of Ig-Tg B cells  to  sHEL in the bone 
marrow did not prevent migration to the spleen, once there, 
those B cells capable of binding HEL were apparently elimi- 
nated within 3-4 d. This  10-fold reduction in life span,  al- 
though  less efficient than  that  observed in the presence of 
membrane HEL, is consistent with significant  purging of self- 
reactive B cells. 
The mechanism responsible for the shortened life span of 
mature self-reactive B cells is unclear.  According to conven- 
tional dogma, deletion depends on cross-linking  of Ig-receptors 
above a critical threshold (27). In the current model, this may 
have occurred in sHEL Dbl-Tg mice as a result of encounter 
with high concentrations of cross-linked HEL on the follic- 
ular dendritic cells in the spleen or by interaction with cir- 
culating multivalent antigen since lysozymes including HEL 
are known to complex with serum proteins such as a-2 mac- 
roglobulin (reference 28 and Fulcher, D., and P. Peake, un- 
published observations) or with themselves.  Alternatively the 
reduced life span of anergic B cells could have been due to 
negative signaling related to binding of self-antigen at an im- 
mature stage of development in the bone marrow (27) and/or 
by the failure to receive T cell help.  To distinguish between 
these two possibilities it would be interesting to determine 
the fate of immature vs. mature Ig-Tg B cells after transfer 
into soluble HEL-Tg recipients.  Irrespective of the mecha- 
nism, however, the data on life span presented here suggest 
that  anergy and deletion may not be entirely discrete enti- 
ties, but rather represent a continuum with the anergic state 
being the harbinger  of delayed deletion. 
If anergy is indeed a form of delayed deletion and anergic 
self-reactive B cells have a relatively short life span in periph- 
eral lymphoid tissue, these findings have significant implica- 
tions for our understanding of self-tolerance and autoimmu- 
nity. For example the opportunity for B cells with specificity 
for soluble self-antigen to escape from self-tolerance and to 
mount a pathogenic autoimmune response is reduced since 
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state. Interestingly, it is now apparent from work in our model 
and those of others (Crosbie, J., unpublished observations, 
and references 30-32) that Ig-Tg B cells can lose self-reactivity 
and escape deletion by the process of receptor editing. The 
current experiments are consistent with such a conclusion 
since a loss of HEL binding was associated with a return in 
B cell life span to control values (Fig.  3 D).  It remains to 
be determined whether this involves active rearrangement of 
endogenous light chain genes by expression of recombinase 
activator genes (31), or whether it involves the selection of 
rare cells that have suppressed their light chain transgene during 
development in favor of the endogenous gene in a stochastic 
manner. In either case, an attempt by anergic B cells to rear- 
range endogenous light chain genes in order to escape self- 
reactivity would allow them to generate potentially useful 
foreign specificities. On the other hand, anergic self-reactive 
B cells that are destined to die within a few days of reaching 
peripheral lymphoid tissue are  unlikely to be particularly 
efficient in inducing unresponsiveness in the T cell repertoire 
as has recently been suggested by some investigators for small 
resting B cells (33, 34). Nevertheless,  the inclusion of anergy 
within the spectrum of deletion does raise the question of 
whether the high attrition rate of newly generated B cells 
on reaching the periphery of normal mice, estimated to be 
"~50% (Fulcher,  D., and A. Basten, manuscript in prepara- 
tion), might be explained at least in part by an elimination 
mechanism of this kind with the potential to act at multiple 
stages during development of self-reactive  B cells. 
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